Most of the chronic diseases including diabetes mellitus are difficult to treat successfully with orthodox drugs. Investigation in complementary and alternative medicines is now being intensified to proffer lasting solution. Natural products and their derivatives may be considered as a potential source of novel compounds which can combine with orthodox drugs to enhance their hypoglycemic effect. To investigate the complementary and synergistic effect of Catharanthus roseus (C. roseus) leaves extract with oral hypoglycemic synthetic drugs sulphonylurea (glibenclamide) and biguanide (metformin). Experimental induction of diabetes in rats using alloxan model was employed. Five rats each of six groups were used. Group I received distilled water only. Groups II, III and IV received 250 mg/kg of methanol extract, 100 mg/kg of biguanide (metformin) and 1 mg/kg of sulphonylurea (glibenclamide), respectively. Groups V and VI received extract-metformin and extractglibenclamide combination at doses as above, respectively. Administration of the six groups was carried out once daily for seven days. At 2, 12, 24, 72 and 168 h, fasting blood glucose was determined using a glucometer. When compared with control alone, all medicaments significantly (p<0.05) lowered blood glucose levels. The highest percentage reduction in blood glucose (64.9%) occurred with extract-biguanide (metformin) combination. The leaves extract of C. roseusbiguanide (metformin) combination offered a promising novel approach to diabetes mellitus treatment.
Introduction
The concomitant use of medicinal plants and drugs especially in Africa is a growing tendency because of the difficulty in successfully treating some chronic diseases such as diabetes mellitus with orthodox drug 1, 2 . It is estimated that Nigeria, South Africa, Kenya, and Cameroun top the list of countries with the prevalence of DM in each sub-region of Africa affecting 3.2, 2, over 0.7, and over 0.5 million people respectively 3 15 . The aim of this study was to investigate a possible novel approach for treatment of diabetes mellitus based on C.
roseus-orthodox oral hypoglycemic combination therapy.
Materials and Method

Plant material preparation and extraction
The fresh stalks of C. roseus were collected from Calabar 
Animals
Thirty albino rats of both sexes (160 -220 g) obtained in the Laboratory Animals facility of the Department of Pharmacology and Toxicology, Madonna University, Elele were used in the studies. Under standard laboratory situations, the animals were maintained having free access to standard pellets (Vital Feeds Plc, Nigeria) and clean water. The animals were transferred to work area and allowed for two weeks of acclimatization.
Experimental protocols
The Alloxan-induced diabetes test, animal grouping, and determination of blood glucose were performed as previously Animal were considered diabetic when a blood-glucose level is greater than 150 mg/dL.
The animals were grouped in six, and each contain5 rats according to similar weights were employed. Group 1 served as control and received orally 0.2 mL of distilled water once daily.
Group II received orally 250 mg/kg of extract daily. Group III received orally metformin 100 mg/kg daily. Group IV received orally 1 mg/kg of glibenclamide, daily. Group V received orally a combination of 100 mg/kg metformin and 250 mg/kg extract, daily, while Group VI received orally a combination of 1 mg/kg glibenclamide and 250 mg/kg extract, daily. All administration was done for seven days.
In the determination of blood glucose, glucometer (Prestige smart systems) was used. Blood samples were collected from the cut tail-tip of conscious rat and the glucose test-strip soaked with the blood and allowed to dry for 60 seconds and then inserted to be read by the glucometer. Basal and 48 hours postinduction blood glucose levels were recorded. Thereafter, the drug, extract or drug-extract combination was administered daily for 7 days. At 2 h, 12 h, 24 h, 72 h, and 168 h, blood glucose concentrations were measured and recorded.
Statistical analysis
The generated data were expressed as mean ± standard error of mean (SEM). Statistical comparisons were performed by oneway ANOVA, followed by Tukey-Kramer multiple comparisons test and Student-Newman-Keuls multiple comparisons test and the values were considered statistically significant when p value is less than 0.05 (p<0.05)
Results
The control group throughout the experimental period did not show any significant (p>0.05) reduction in the blood glucose level ( Table 1) . The blood sugar level of the extract-drug combinations and extract alone at 2 h showed significant (p<0.01 and p<0.05, respectively) difference in comparison with the control. The standard drug alone did not show significant (p>0.05) difference. Greater significant (p<0.01) difference was shown by metformin as well as extract-metformin combination.
At 168 h, all treatment groups showed significant variations compared with control. Interestingly, extract-metformin combination showed extremely significant (p<0.01) difference when compared with metformin alone, which showed the highest percentage reduction (64.9%) in blood glucose by the extract-metformin combination at 72 h.
Discussions
The results obtained in this study revealed that methanol extracts of C. roseus concomitantly given with metformin showed great percentage in reduction of blood glucose as well as synergy. However, glibenclamide-metformin combination was less pronounced in lowering the blood glucose effect than are known to reduce the concentration of glucose in the blood.
Glibenclamide achieves this primarily by stimulating a firstphase release of insulin from functioning pancreatic beta cells in response to endogenous insulin thereby reducing insulin resistance, while metformin stimulates tissues uptake of glucose and increase insulin receptor binding 16, 17 . 18, 14 .
In addition to mechanisms of action of herb and drugs (pharmadynamic factor) pharmacokinetics considerations of interaction such as enzyme inhibition may have contributed in delaying the appearance of significant difference between metformin monotherapy and extract-metformin combination therapy until the 7 th day. Alteration of absorption (pharmacokinetics factor) due to binding has been reported with co-administration of some herbs 20 , resulting in no significant changes in hypoglycemic activity of the orthodox drugs.
Conclusion
The leaves extracts of C. roseus-metformin combination therapy was synergistic and showed higher hypoglycemic effect than any of the two monotherapy. This finding may provide a novel approach to diabetes mellitus treatment.
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